Literature DB >> 30243685

Surgeon Volume in Benign Gynecologic Surgery: Review of Outcomes, Impact on Training, and Ethical Contexts.

Laura M Glaser1, Lacey Brennan2, Louise P King2, Magdy P Milad3.   

Abstract

It is becoming increasingly clear that surgeon volume affects surgical outcomes. High-volume surgeons demonstrate reduced perioperative complications, shorter operative times, and reduced blood loss during multiple modalities of benign gynecologic surgery. Furthermore, high-volume surgeons consistently demonstrate higher rates of minimally invasive approaches, low rates of conversion to laparotomy, and lower per-procedure case costs. It is suggested that surgeons who have completed postresidency training have improved surgical outcomes, although these data are limited. Surgical exposure in obstetrics and gynecology residency is varied and does not consistently meet demonstrated surgical learning curves. Deficiencies in residency surgical training may be related to the volume-outcome relationship. We suggest reforming residency surgical training and tracking postresidency practice to provide optimal surgical care. Additionally, surgeons may have an ethical obligation to inform patients of their surgical volume and outcomes, with options for referrals if needed.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Ethics; Surgical outcomes; Training; Volume

Mesh:

Year:  2018        PMID: 30243685     DOI: 10.1016/j.jmig.2018.09.775

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  2 in total

1.  Ob/Gyn resident self-perceived preparedness for minimally invasive surgery.

Authors:  Jordan S Klebanoff; Cherie Q Marfori; Maria V Vargas; Richard L Amdur; Catherine Z Wu; Gaby N Moawad
Journal:  BMC Med Educ       Date:  2020-06-05       Impact factor: 2.463

Review 2.  Strategies for Cost Optimization in Minimally Invasive Gynecologic Surgery.

Authors:  Youssef Youssef; Huda Afaneh; Mostafa A Borahay
Journal:  JSLS       Date:  2022 Jul-Sep       Impact factor: 1.789

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.